Correcting the ASCO position on phase I clinical trials in cancer
Correcting the ASCO position on phase I clinical trials in cancer
Related Articles
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Welcome! You are invited to join a webinar: Post-ASCO 2025 GI & ESMO Cancer Highlights. After registering, you will receive a confirmation email about joining the webinar.
Virtual webinar hosted by VJOncology featuring presentations & discussions on selected abstracts in GI cancer from ASCO 2025. Chaired by Dr Lorenza Rimassa Moderated by…
Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer
This cohort study compares the performance of digital breast tomosynthesis to conventional digital mammography in screening women with a family history of breast cancer.
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer | NEJM
Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms.…
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer | NEJM
Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms.…
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer | NEJM
Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms.…